2016 EULAR Congress Poster Presentation

Our data that baseline low expression of ADAMTS5 can predict the efficacy of infliximab was validated using multi-center clinical trial.

Poster(2016_EULAR).pdf

Adobe Acrobat Document 935.5 KB

Kaytee Bio Co.&Ltd.

<Headquarter

&Laboratory>

Room #505,

Yamaguchi Bdg,

Funabashi,

4-38-22, Honcho,

Funabashi,

Chiba 273-0005, JAPAN

TEL: +81474110017

FAX: +81474110018

Case Reports of Talin Test

▶️Multi-center trial for the efficacy of infliximab